Comments
Loading...

Inhibrx Biosciences

INBXNASDAQ
Logo brought to you by Benzinga Data
$16.99
00.00%
Pre-Market: 4:00 PM EDT
15 minutes delayed
Consensus Rating1
Outperform
Highest Price Target1
$60.00
Lowest Price Target1
$35.00
Consensus Price Target1
$45.25

Inhibrx Biosciences (NASDAQ:INBX) Stock, Analyst Ratings, Price Targets, Forecasts

Inhibrx Biosciences Inc has a consensus price target of $45.25 based on the ratings of 5 analysts. The high is $60 issued by Evercore ISI Group on October 5, 2022. The low is $35 issued by JMP Securities on May 10, 2023. The 3 most-recent analyst ratings were released by JMP Securities on November 20, 2023, August 23, 2023, and May 10, 2023, respectively. With an average price target of $29.67 between JMP Securities, there's an implied 74.61% upside for Inhibrx Biosciences Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Jul
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.7
Strong Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

JMP Securities
Credit Suisse
Evercore ISI Group
SMBC Nikko

1calculated from analyst ratings

Analyst Ratings for Inhibrx Biosciences

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Inhibrx Biosciences (INBX) stock?

A

The latest price target for Inhibrx Biosciences (NASDAQ:INBX) was reported by JMP Securities on July 23, 2024. The analyst firm set a price target for $0.00 expecting INBX to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Inhibrx Biosciences (INBX)?

A

The latest analyst rating for Inhibrx Biosciences (NASDAQ:INBX) was provided by JMP Securities, and Inhibrx Biosciences initiated their market perform rating.

Q

When was the last upgrade for Inhibrx Biosciences (INBX)?

A

There is no last upgrade for Inhibrx Biosciences

Q

When was the last downgrade for Inhibrx Biosciences (INBX)?

A

The last downgrade for Inhibrx Biosciences Inc happened on January 23, 2024 when JMP Securities changed their price target from N/A to N/A for Inhibrx Biosciences Inc.

Q

When is the next analyst rating going to be posted or updated for Inhibrx Biosciences (INBX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Inhibrx Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Inhibrx Biosciences was filed on July 23, 2024 so you should expect the next rating to be made available sometime around July 23, 2025.

Q

Is the Analyst Rating Inhibrx Biosciences (INBX) correct?

A

While ratings are subjective and will change, the latest Inhibrx Biosciences (INBX) rating was a initiated with a price target of $0.00 to $0.00. The current price Inhibrx Biosciences (INBX) is trading at is $16.99, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch